These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32580757)
1. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study. Guo W; Song F; Chen S; Zhang L; Sun G; Liu J; Chen J; Liu Y; Tan N; Trials; 2020 Jun; 21(1):567. PubMed ID: 32580757 [TBL] [Abstract][Full Text] [Related]
2. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Mandurino-Mirizzi A; Kajana V; Cornara S; Somaschini A; Demarchi A; Galazzi M; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2140-2143. PubMed ID: 34039505 [TBL] [Abstract][Full Text] [Related]
3. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903 [TBL] [Abstract][Full Text] [Related]
4. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538 [TBL] [Abstract][Full Text] [Related]
5. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Velibey Y; Oz A; Tanik O; Guvenc TS; Kalenderoglu K; Gumusdag A; Akdeniz E; Bozbay M; Tekkesin AI; Guzelburc O; Hayiroglu MI; Alper AT; Ugur M; Eren M Angiology; 2017 May; 68(5):419-427. PubMed ID: 27473864 [TBL] [Abstract][Full Text] [Related]
6. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134 [TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit? Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention. Lin KY; Chen HC; Jiang H; Wang SY; Chen HM; Wu ZY; Jiang F; Guo YS; Zhu PL BMC Nephrol; 2020 Mar; 21(1):90. PubMed ID: 32156263 [TBL] [Abstract][Full Text] [Related]
9. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Silvain J; Nguyen LS; Spagnoli V; Kerneis M; Guedeney P; Vignolles N; Cosker K; Barthelemy O; Le Feuvre C; Helft G; Collet JP; Montalescot G Heart; 2018 May; 104(9):767-772. PubMed ID: 29092921 [TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial. Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial. Song F; Sun G; Liu J; Chen JY; He Y; Liu L; Liu Y; Trials; 2019 May; 20(1):290. PubMed ID: 31133052 [TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention. Guo W; Liu Y; Chen JY; Chen SQ; Li HL; Duan CY; Liu YH; Tan N Angiology; 2015 Sep; 66(8):721-6. PubMed ID: 25616679 [TBL] [Abstract][Full Text] [Related]
13. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293 [TBL] [Abstract][Full Text] [Related]
14. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention. Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between carbon dioxide combining power and contrast- induced acute kidney injury in patients with ST segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention]. Ran P; Yang J; Yang X; Zhou Y; Tan N; He Y; Li G; Sun S; Liu Y; Xie N; Chen J Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):551-6. PubMed ID: 25327595 [TBL] [Abstract][Full Text] [Related]
19. Effect of acute kidney injury on long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent primary percutaneous coronary intervention in a high-volume tertiary center. Hayıroğlu Mİ; Bozbeyoglu E; Yıldırımtürk Ö; Tekkeşin Aİ; Pehlivanoğlu S Turk Kardiyol Dern Ars; 2020 Jan; 48(1):1-9. PubMed ID: 31974325 [TBL] [Abstract][Full Text] [Related]
20. Predictors of acute kidney injury (AKI) in high-risk ST-elevation myocardial infarction (STEMI) patients: A single-center retrospective observational study. Sinkovič A; Masnik K; Mihevc M Bosn J Basic Med Sci; 2019 Feb; 19(1):101-108. PubMed ID: 30589402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]